<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fifteen patients with various myeloid and lymphoid <z:hpo ids='HP_0002664'>neoplasias</z:hpo> after receiving highly myelotoxic chemotherapy were treated with a single daily dose of 5 micrograms/kg of GM-CSF </plain></SENT>
<SENT sid="1" pm="."><plain>G-CSF at a daily dose of 5-8 micrograms/kg was used in four patients with severe <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in the course of <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo> treated with cytotoxic agents, and in two patients with idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The administration of cytokines was provided for 4-10 days GM-CSF increased the WBC in twelve out of fifteen patients, mainly because of an increase in the number of neutrophils </plain></SENT>
<SENT sid="3" pm="."><plain>Six patients receiving GM-CSF demonstrated rapid platelet recoveries </plain></SENT>
<SENT sid="4" pm="."><plain>The rapid increase of the WBC was observed in <z:hpo ids='HP_0000001'>all</z:hpo> G-CSF treated patients </plain></SENT>
<SENT sid="5" pm="."><plain>In one patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> the WBC/ANC decreased rapidly to the initial values after the cessation of the G-CSF therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Fast platelet recovery was seen in three patients treated with G-CSF </plain></SENT>
</text></document>